TY - JOUR
T1 - A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation
AU - Buzzatti, Nicola
AU - Montorfano, Matteo
AU - Romano, Vittorio
AU - De Backer, Ole
AU - Soendergaard, Lars
AU - Rosseel, Liesbeth
AU - Maurovich-Horvat, Pal
AU - Karady, Julia
AU - Merkely, Bela
AU - Prendergast, Bernard
AU - De Bonis, Michele
AU - Colombo, Antonio
AU - Latib, Azeem
N1 - Funding Information:
A. Latib has received consultant fees from Abbott, Edwards Lifesciences and Medtronic and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences and Medtronic. The other authors have no conflicts of interest to declare.
Funding Information:
O. De Backer has received consultant fees from Abbott and Boston Scientific. L. Søndergaard has received consultant fees and institutional research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic and Symetis. B. Prendergast has received institutional research grants from Edwards Lifesciences. M. De Bonis has received consultant fees from Abbott Vascular and Medtronic. M. Montorfano has received consultant fees from Abbott Vascular, Boston Scientific and Edwards Lifesciences.
Publisher Copyright:
© Europa Digital & Publishing 2020.
PY - 2020
Y1 - 2020
N2 - Aims: The aim of this study was to investigate the risk of impaired coronary access and coronary obstruction after redo TAVI. Methods and results: Post-procedure multidetector computed tomography (MDCT) scans of 221 TAVI recipients were analysed. Increased risk of impaired coronary access was defined as a coronary ostium below the TAVI commissures with a valve-to-aorta distance <2 mm at this level. Increased risk was found in 123 (55.6%) cases: The left main was involved in 109 (49.3%), the right coronary in 79 (35.7%), and both were involved in 65 (29.4%) patients. A small sinotubular junction (STJ width OR 0.68, CI: 0.56-0.81, p<0.001; STJ height OR 0.81, CI: 0.69-0.95, p<0.011) and supra-annular devices (OR 19.8, CI: 6.6-58.8, p<0.001) predicted increased risk. Increased risk of coronary obstruction, defined as a coronary ostium below the TAVI commissures with a valve-to-coronary distance <2 mm, was observed in 14.9% of patients; in 17.2% of cases complete sealing of the STJ would occur. Conclusions: Post-TAVI MDCT suggested an increased potential risk of impaired coronary access in more than half of the patients should redo TAVI be required, predicted by a small STJ and supra-annular device design. Furthermore, 10-20% of patients presented an increased risk of coronary obstruction. While this theoretical study is hypothesis-generating, it raises concerns that need to be further investigated and addressed before TAVI is extended to patients with longer life expectancy.
AB - Aims: The aim of this study was to investigate the risk of impaired coronary access and coronary obstruction after redo TAVI. Methods and results: Post-procedure multidetector computed tomography (MDCT) scans of 221 TAVI recipients were analysed. Increased risk of impaired coronary access was defined as a coronary ostium below the TAVI commissures with a valve-to-aorta distance <2 mm at this level. Increased risk was found in 123 (55.6%) cases: The left main was involved in 109 (49.3%), the right coronary in 79 (35.7%), and both were involved in 65 (29.4%) patients. A small sinotubular junction (STJ width OR 0.68, CI: 0.56-0.81, p<0.001; STJ height OR 0.81, CI: 0.69-0.95, p<0.011) and supra-annular devices (OR 19.8, CI: 6.6-58.8, p<0.001) predicted increased risk. Increased risk of coronary obstruction, defined as a coronary ostium below the TAVI commissures with a valve-to-coronary distance <2 mm, was observed in 14.9% of patients; in 17.2% of cases complete sealing of the STJ would occur. Conclusions: Post-TAVI MDCT suggested an increased potential risk of impaired coronary access in more than half of the patients should redo TAVI be required, predicted by a small STJ and supra-annular device design. Furthermore, 10-20% of patients presented an increased risk of coronary obstruction. While this theoretical study is hypothesis-generating, it raises concerns that need to be further investigated and addressed before TAVI is extended to patients with longer life expectancy.
KW - Coronary artery disease
KW - Coronary occlusion
KW - TAVI
UR - http://www.scopus.com/inward/record.url?scp=85098814443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098814443&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-20-00475
DO - 10.4244/EIJ-D-20-00475
M3 - Article
C2 - 32928715
AN - SCOPUS:85098814443
SN - 1774-024X
VL - 16
SP - E1005-E1013
JO - EuroIntervention
JF - EuroIntervention
IS - 12
ER -